NovaBridge Biosciences (NBP) Other Non-Current Liabilities (2018 - 2025)

NovaBridge Biosciences (NBP) has 7 years of Other Non-Current Liabilities data on file, last reported at $512000.0 in Q4 2025.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to $512000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $512000.0 (changed N/A YoY) and the FY2025 annual result came in at $512000.0, changed N/A from the prior year.
• Other Non-Current Liabilities climbed to $512000.0 in Q4 2025 per NBP's latest filing, from -$106000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $2.3 billion in Q4 2021 and bottomed at -$147000.0 in Q2 2022.
• The 5-year median for Other Non-Current Liabilities is $960000.0 (2021), against an average of $261.8 million.
• The widest annual swing landed in 2021, when Other Non-Current Liabilities surged 172378.56%; it then plunged 115.31% in 2022.
• Tracing NBP's Other Non-Current Liabilities over 5 years: stood at $2.3 billion in 2021, then tumbled by 99.9% to $2.4 million in 2022, then surged by 305.67% to $9.7 million in 2023, then slumped by 101.1% to -$106000.0 in 2024, then jumped by 583.02% to $512000.0 in 2025.
• Per Business Quant, the three latest NBP Other Non-Current Liabilities figures stand at $512000.0 (Q4 2025), -$106000.0 (Q3 2024), and -$106000.0 (Q2 2024).

Peer Comparison